Integrated BioPharma (OTCMKTS:INBP) Posts Quarterly Earnings Results

Integrated BioPharma (OTCMKTS:INBP) posted its quarterly earnings data on Friday. The company reported ($0.03) EPS for the quarter, Zacks reports. Integrated BioPharma had a negative return on equity of 1.02% and a negative net margin of 0.40%.

Integrated BioPharma Price Performance

Shares of OTCMKTS:INBP remained flat at $0.25 on Friday. 2,032 shares of the stock traded hands, compared to its average volume of 11,623. Integrated BioPharma has a 1-year low of $0.21 and a 1-year high of $0.42. The stock has a fifty day moving average price of $0.28 and a 200 day moving average price of $0.31. The stock has a market cap of $7.74 million, a price-to-earnings ratio of -12.50 and a beta of 0.41.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products.